Published April 1, 2006 | Version v1
Journal article

Short-course radiotherapy is not optimal for spinal cord compression due to myeloma

  • 1. Department of Radiation Oncology, University Hospital, Hamburg (Germany) and Department of Radiation Oncology, Medical School, Hannover (Germany)
  • 2. Mount Vernon Centre for Cancer Treatment, Northwood, Middlesex (United Kingdom)
  • 3. Department of Radiotherapy, Academic Medical Center, Amsterdam (Netherlands)
  • 4. Department of Radiation Oncology, University Hospital, Lubeck (Germany)
  • 5. Department of Radiation Oncology, Dr. Bernard Verbeeten Institute, Tilburg (Netherlands)
  • 6. Institute of Radiobiology, University Hospital Eppendorf, Hamburg (Germany)
  • 7. Department of Radiotherapy, University Hospital, Sarajevo (Bosnia and Herzegowina)
  • 8. Department of Radiotherapy, Siloah Hospital, Hannover (Germany)
  • 9. Department of Radiotherapy, St. Georg Hospital, Hamburg (Germany)
  • 10. Department of Radiation Oncology, Philipps-University, Marburg (Germany)
  • 11. Department of Radiation Oncology, Mayo Clinic, Scottsdale, AZ (United States)

Description

Purpose: To investigate the suitability of short-course radiotherapy (RT) for spinal cord compression (SCC) in myeloma patients. Methods and Materials: Data for 172 myeloma patients irradiated between January 1994 and December 2004 for SCC were retrospectively evaluated. Short-course RT (1 x 8 Gy, 5 x 4 Gy, n = 61) and long-course RT (10 x 3 Gy, 15 x 2.5 Gy, 20 x 2 Gy, n = 111) were compared for functional outcome up to 24 months after RT. In addition, 10 potential prognostic factors were investigated. Results: Improvement of motor function occurred in 90 patients (52%). Forty-seven percent of nonambulatory patients regained the ability to walk. Functional outcome was significantly influenced by the time of developing motor deficits before RT. Improvement of motor function was more frequent after long-course RT than after short-course RT: 59% vs. 39% (p = 0.10) at 1 month, 67% vs. 43% (p 0.043) at 6 months, 76% vs. 40% (p = 0.003) at 12 months, 78% vs. 43% (p 0.07) at 18 months, and 83% v 54% (p = 0.33) at 24 months. A subgroup analysis of the long-course RT group demonstrated a similar functional outcome for 10 x 3 Gy when compared with 15 x 2.5 Gy and 20 x 2 Gy. Conclusions: Long-course RT is preferable for SCC in myeloma patients because it resulted in better functional outcome than short-course RT. Treatment with 10 x 3 Gy can be considered appropriate

Additional details

Identifiers

DOI
10.1016/j.ijrobp.2005.10.018;
PII
S0360-3016(05)02831-2;

Publishing Information

Journal Title
International Journal of Radiation Oncology, Biology and Physics
Journal Volume
64
Journal Issue
5
Journal Page Range
p. 1452-1457
ISSN
0360-3016
CODEN
IOBPD3

INIS

Country of Publication
United States
Country of Input or Organization
International Atomic Energy Agency (IAEA)
INIS RN
37095070
Subject category
S62: RADIOLOGY AND NUCLEAR MEDICINE;
Descriptors DEI
CENTRAL NERVOUS SYSTEM; IRRADIATION; NERVOUS SYSTEM DISEASES; PATIENTS; RADIOTHERAPY; SPINAL CORD
Descriptors DEC
CENTRAL NERVOUS SYSTEM; DISEASES; MEDICINE; NERVOUS SYSTEM; NUCLEAR MEDICINE; RADIOLOGY; THERAPY

Optional Information

Copyright
Copyright (c) 2006 Elsevier Science B.V., Amsterdam, The Netherlands, All rights reserved.